18 results with keyword: 'targeting b cell receptor signaling leukemia lymphoma'
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406...
N/A
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
N/A
(2009) B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor,
N/A
In the present study, we showed that primary MCL cells displayed a constitutive and BCR-induced activation of LYN and that treatment with dasatinib or with a more specific inhibitor
N/A
In the present study, we showed that primary MCL cells displayed a constitutive and BCR-induced activation of LYN and that treatment with dasatinib or with a more specific inhibitor
N/A
ABC: Activated B-Cell like; AIF1: Allograft Inflammatory Factor 1; BCL11B: B-Cell leukemia/ lymphoma 11B; BCR: B-Cell Receptor; CNV: Copy Number Variation; COO:
N/A
leukemia; pre T-LBL, precursor T-cell lymphoblastic leukemia/lymphoma; AML, acute myeloid leukemia; DLBCL, diffuse large B-cell lymphoma; ALL, acute lymphocytic leukemia; T-ALL,
N/A
The emissions are projected to increase significantly: According to the third IMO GHG study (IMO 2014), the emissions are ex pected to increase by 50 to 250% in the
N/A
Burkitt lymphoma Hairy cell leukemia Chronic myelomonocytic leukemia Mantle cell lymphoma Plasmacytoma T-cell leukemia T-cell lymphoma Myelodysplastic syndroms
N/A
Mantle cell lymphoma Diffuse large B-cell lymphoma Burkitt lymphoma/Burkitt cell leukemia T-cell and NK-cell neoplasms.. Precursor
N/A
CLL in prolymphocytic transformation B-cell prolymphocytic leukemia Mantle cell lymphoma, blastoid variant Follicular lymphoma, transformed Diffuse large B-cell lymphoma
N/A
B-cell chronic lymphocytic leukemia; B-NHL: B-cell non-Hodgkin’s lymphoma; BCL: B-cell lymphoma; DLBCL: Diffuse large B-cell lymphoma; EBV: Epstein–Barr virus; EGFR:
N/A
ABC, activated B-cell; ATLL, acute T-cell leukemia/lymphoma; BENTA, B-cell expansion with NF-kB and T-cell anergy; BCR, B-cell receptor; CBM, CARMA1/BCL10/MALT1; CTLA-4, cytotoxic
N/A
Chronic lymphocytic leukemia/small lymphocytic lymphoma · Clonal evolution · Diffuse large B-cell lymphoma · Follicular lymphoma · Intratumoral heterogeneity · Lymphoma
N/A
A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. LAB: a new membrane- associated adaptor molecule in B
N/A
BITEs: Bispecific T-cell engagers; CAR: Chimeric antigen receptor; CLL: Chronic lymphocytic leukemia; DLBCL: Diffuse large B cell lymphoma; IRAEs: Immune- related adverse events;
N/A
SMZL, splenic marginal zone lymphoma; DLBCL, diffuse large B-cell lymphoma; LPD, lymphoproliferative disease; SBCL/L, NOS, small B-cell lymphoma/ leukemia not otherwise specified;
N/A